In this episode Mike Ward, head of the firm’s Life Sciences group, discusses the path toward a vaccine for COVID-19 focusing on the science with Otis Littlefield, and on legal considerations including regulatory with Bethany Hills; and commercial transactions with Rufus Pichler.